Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?

Controversy exists regarding the optimal use of the 23-valent pneumococcal conjugate vaccine for the protection of high-risk individuals, such as children and adults with immunocompromising conditions and the elderly. The effectiveness and immunogenicity of 23-valent pneumococcal polysaccharide vacc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and vaccine immunology 2016-05, Vol.23 (5), p.388-395
Hauptverfasser:	Papadatou, Ioanna, Spoulou, Vana
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Child Humans Immune Tolerance Immunization Schedule Immunization, Secondary Immunocompromised Host Immunogenicity, Vaccine Minireview Pneumococcal Infections - immunology Pneumococcal Infections - microbiology Pneumococcal Infections - prevention & control Pneumococcal Vaccines - administration & dosage Pneumococcal Vaccines - immunology Pneumococcal Vaccines - standards Pneumonia, Pneumococcal - prevention & control Risk Factors Streptococcus pneumoniae Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!